Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-10-08Clinical Trial Update: Effect of Different Fat Enriched Meats on the Hepatic Cholesterol Synthesis [NA]
A completed clinical trial (NCT02259153) evaluated how fat-enriched meats influence hepatic cholesterol synthesis.
-
CLINICAL_TRIALS trial_result · 2014-10-07Clinical Trial Update: Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients [Phase 4]
Phase 4 clinical trial update on salusin-α for lipid abnormalities in hemodialysis patients, with the study conducted by Poznan University o…
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: RCT Examining Effects of Probiotics in T2DM Individuals [NA]
This entry notes a randomized clinical trial evaluating the effects of probiotics in individuals with Type 2 Diabetes Mellitus and related c…
-
FDA approval · 2014-09-30FDA Approved: ZETIA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ZETIA (ezetimibe) submitted by Organon LLC. The approval updates the product labeling to reflect…
-
FDA approval · 2014-09-23FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries Inc.)
FDA approved a supplemental application for atorvastatin calcium from Sun Pharmaceutical Industries Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-09-23FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for atorvastatin calcium by Mylan Pharmaceuticals, confirming the approval of a generic version of t…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Veterans Service Organizations and My HealtheVet (MHV) [NA]
The VA-sponsored trial evaluating My HealtheVet in veterans with hypertension and hyperlipidemia has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction [Phase 4]
Phase 4 open-label trial comparing ezetimibe, niacin, and colestipol as adjunct therapy for lipid reduction; results were posted in 2014.
-
CLINICAL_TRIALS research · 2014-07-29Clinical Trial Update: Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia [NA]
A clinical trial update describing an efficacy and safety study of dietary supplements in chronic smokers with hyperlipidemia; no results or…
-
FDA approval · 2014-07-28FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for the fixed-dose combination of amlodipine and atorvastatin (amlodipi…
-
CLINICAL_TRIALS trial_result · 2014-07-23Clinical Trial Update: Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia [Phase 2]
This clinical trial update reports on the Phase 2 efficacy and safety evaluation of XueZhiKang (XZK), a lipid-lowering agent, in adults with…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia [Phase 3]
Phase 3 trial comparing YH16410 with rosuvastatin and telmisartan monotherapies in patients with hypertension and hyperlipidemia; the study …
-
FDA approval · 2014-07-01FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (CIPLA USA INC.)
The FDA approved a supplemental application for Pravastatin Sodium by Cipla USA Inc.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America
A completed clinical trial evaluating the effectiveness and safety of Niaspan for lipid abnormalities in Latin America; results were posted …
-
CLINICAL_TRIALS research · 2014-05-26Clinical Trial Update: The Effect of Extract of Green Tea on Obese Women and Obese Related Hormone Peptides [Phase 2, Phase 3]
A Phase 2/Phase 3 trial investigates the effects of green tea extract on obese women and obesity-related hormone peptides; the study status …
-
CLINICAL_TRIALS research · 2014-05-23Clinical Trial Update: Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers [NA]
A completed Tufts University study evaluates how dietary amino acid profiles affect lipoprotein metabolism, vascular reactivity, and inflamm…
-
FDA approval · 2014-05-22FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for a fixed-dose combination of amlodipine and atorvastatin (amlodipine besylate and atorvastatin ca…
-
FDA label_change · 2014-05-22FDA Approved: COLESTID — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental labeling application for COLESTID (colestipol hydrochloride) submitted by Pharmacia & Upjohn Company LLC to …
-
FDA approval · 2014-05-22FDA Approved: COLESTID — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for COLESTID (colestipol hydrochloride) submitted by Pharmacia & Upjohn Company LLC.
-
FDA approval · 2014-05-20FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc. The action ap…
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus [NA]
This update reports a completed clinical trial evaluating the efficacy of Colesevelam in subjects with Type 1 diabetes mellitus and hyperlip…
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness [NA]
Completed clinical trial on point-of-care testing for detection and management of metabolic syndrome in patients with mental illness.
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV [NA]
A National Heart, Lung, and Blood Institute-sponsored trial evaluated acipimox for improving hyperlipidemia and insulin sensitivity in HIV-i…
-
FDA approval · 2014-05-14FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans [Phase 2, Phase 3]
Phase 2/3 trial evaluating sitagliptin's effects on intestinal and hepatic lipoprotein particles and hepatic glucose production in humans wi…